Both in Pharmaceuticals
Oramed Pharmaceuticals vs AN2 Therapeutics
Over the past year ORMP returned +73.7% and ANTX returned +296.1%; their daily moves had a correlation of 0.08.
ORMP +73.7% ANTX +296.1%Growth of $1, one year, split-adjusted
| Metric | ORMP | ANTX |
|---|---|---|
| Price | $4.69 | $5.09 |
| Market cap | $195.1M | $192.1M |
| Today | −1.26% | +1.60% |
| 1 month | −6.8% | −8.8% |
| 6 months | +43.0% | +47.1% |
| Year to date | +64.6% | +346.5% |
| 1 year | +94.6% | +307.2% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | 1.1× | — |
| Price / sales | — | — |
| Net cash | $50.6M | $78.4M |
| Dividend yield | 5.33% | — |
| Volatility (60d) | 42.1% | 52.6% |
| Short % of float | 3.9% | 9.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).